Browsing by Author Xuereb, Robert G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 38 of 38
Issue DateTitleAuthor(s)
2014Antiplatelet and anticoagulant therapy for non-ST-elevation acute coronary syndromes in a general hospitalMason, Giorgia; Wirth, Francesca; Cignarella, Andrea; Xuereb, Robert G.; Azzopardi, Lilian M.
2013-10Antiplatelet and anticoagulation treatment for non-ST-elevation acute coronary syndromesMason, Giorgia; Wirth, Francesca; Azzopardi, Lilian M.; Xuereb, Robert G.; Cignarella, Andrea
2019-03Assessing medication adherence and condition-related knowledge of heart failure patientsDebono, Ivan; Grech, Louise; Xuereb, Robert G.; Azzopardi, Lilian M.
2015-06Association of the CYP2C19 *2 allele on the occurrence of in-stent restenosis in patients undergoing coronary stentingWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2010Atrial fibrillation : a common arrhythmia with possible dire consequencesXuereb, Robert G.
2019-09Cardiac rehabilitation and smoking statusAnders, Henry O.; Wirth, Francesca; Gauci, Marilyn; Xuereb, Clifford; Desira, Josette; Xuereb, Robert G.; Azzopardi, Lilian M.
2020Comparative analysis of lipid profile management in ischaemic heart diseaseZarb, Maia; Xuereb, Robert G.; Wirth, Francesca; Azzopardi, Lilian M.
2015-10Comparison between a point-of-care and a laboratory-based CYP2C19*2 genotyping assay for pharmacist-led personalisation of antiplatelet therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2016Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
1992Coronary artery spasm : role in acute myocardial ischaemiaXuereb, Robert G.; Xuereb, Mariosa
2019-02CYP2C19 genetic polymorphisms in Maltese patients on clopidogrel therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Camilleri, Liberato; Fenech, Albert; Azzopardi, Lilian M.
2021CYP2C19* 2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel : a matched case-control studyOsama, Sara; Wirth, Francesca; Zahra, Graziella; Barbara, Christopher; Xuereb, Robert G.; Camilleri, Liberato; Azzopardi, Lilian M.
2018CYP2C19*2 allele carrier status and coronary in-stent restenosis : is there an association?Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Camilleri, Liberato; Fenech, Albert; Azzopardi, Lilian M.
2020CYP2C19*2 genetic polymorphism and other predictors for coronary in-stent restenosis in patients on clopidogrel therapyOsama, Sara; Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Azzopardi, Lilian M.
2020Evaluating the safety and tolerability of sacubitril/valsartanVandenbroeke, Helena; Wirth, Francesca; Xuereb, Robert G.; Steurbaut, Stephane; Azzopardi, Lilian M.
2023-04Experience with statin therapy in patients undergoing cardiac proceduresCalleja, Jean Claude; Wirth, Francesca; Xuereb, Robert G.; Azzopardi, Lilian M.
2016Female gender and cardiovascular diseaseXuereb, Rachel; Magri, Caroline J.; Xuereb, Sara; Xuereb, Mariosa; Zammit-Mangion, Marion; Xuereb, Robert G.
2017-10Impact of rivaroxaban in cardiovascular diseaseCardona, Mark; Wirth, Francesca; Serracino-Inglott, Anthony; Xuereb, Robert G.; Azzopardi, Lilian M.
2003The long and winding road: the management of Acute Coronary Syndromes in MaltaXuereb, Robert G.; Xuereb, Mariosa
2018-10Low density lipoprotein control in patients with ischaemic heart diseaseCurtolo, Elisa; Wirth, Francesca; Xuereb, Robert G.; Camilleri, Liberato; Cignarella, Andrea; Azzopardi, Lilian M.
2014Non-dipping heart rate and microalbuminuria in type 2 diabetes mellitusMagri, Caroline Jane; Xuereb, Robert G.; Fava, Stephen
2011Peroxisome proliferator-activated receptor-γ and the endothelium : implications in cardiovascular diseaseMagri, Caroline Jane; Gatt, Noel; Xuereb, Robert G.; Fava, Stephen
2015-06Pharmacist-led CYP2C19 genotyping in patients on clopidogrel therapy following percutaneous coronary interventionWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2016-03Pharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapyWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2019-03Pharmacogenetic testing for personalisation of statin therapyCerdá Iñesta, Judith; Wirth, Francesca; Mifsud Buhagiar, Luana; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony
2015-10Point-of-care CYP2C19 genotyping in patients prescribed clopidogrel therapy following a percutaneous coronary interventionWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2015-09Prevalence of the CYP2C19 *2 allele in Maltese patients on clopidogrel therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2017-01Rapid point-of-care CYP2C19*2 genotyping to personalise antiplatelet therapy in patients undergoing coronary stentingWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2018Relationship of hyperglycaemia, hypoglycaemia, and glucose variability to atherosclerotic disease in type 2 diabetesMagri, Caroline Jane; Mintoff, Dillon; Camilleri, Liberato; Xuereb, Robert G.; Galea, Joseph; Fava, Stephen
2016-10Retrospective analysis of serum digoxin concentrations at Mater Dei HospitalVella, John; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2016-10Safer anticoagulation management in the community : a pharmacist-led approachMifsud, Elena Marie; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2022Six months after the patients stayed home : a nationwide study of cardiac mortality and readmissions following the first wave of the COVID-19 pandemic in MaltaGrech, Neil; Xuereb, Rachel A.; Xuereb, Robert G.; Caruana, Maryanne
2018-09SLCO1B1 genetic polymorphisms in cardiac patients on simvastatinCerdá Iñesta, Judith; Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony
2014Smoking ban : a long-term analysis of the Malta paradox in a population of over 400,000 subjectsXuereb, Robert G.; Distefano, Sandra; Magri, Caroline Jane; Calleja, Neville; Grech, Victor E.
2020Smoking cessation in post-hospitalisation cardiac rehabilitationScicluna, Gabrielle; Gauci, Marilyn; Xuereb, Clifford; Desira, Josette; Xuereb, Robert G.; Wirth, Francesca; Azzopardi, Lilian M.
2008Transcatheter device closure of atrial septal defect and patent foramen ovale in MaltaGrech, Victor E.; Aquilina, Oscar; Felice, Herbert; Fenech, Albert; Xuereb, Robert G.; Xuereb, Mariosa; Tilney, Terrence; Aquilina, Josanne; Vella, Norbert; Galea Debono, Anthony; DeGiovanni, Joseph V.
2009‘Twiddling’ of the pacemaker resulting in lead dislodgementCassar DeMarco, Daniela; Xuereb, Robert G.
2022When the patients stayed home : the impact of the COVID-19 pandemic on acute cardiac admissions and cardiac mortality in MaltaGrech, Neil; Xuereb, Rachel; England, Kathleen; Xuereb, Robert G.; Caruana, Maryanne